about
Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liverAdenoviral vectors for prodrug activation-based gene therapy for cancerSulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.Spermidinyl-CoA-based HAT inhibitors block DNA repair and provide cancer-specific chemo- and radiosensitization.Oncolytic bluetongue viruses: promise, progress, and perspectivesNatural products as potential cancer therapy enhancers: A preclinical update.Natural paniceins from mediterranean sponge inhibit the multidrug resistance activity of Patched and increase chemotherapy efficiency on melanoma cellsImproving adenovirus based gene transfer: strategies to accomplish immune evasion.The oncolytic virus ΔPK has multimodal anti-tumor activity.Combination of Sasa quelpaertensis Nakai leaf extract and cisplatin suppresses the cancer stemness and invasion of human lung cancer cells.Viral gene therapy for breast cancer: progress and challenges.Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract.Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.Mulberry leaf extract inhibits cancer cell stemness in neuroblastoma.Method to Screen Multidrug Transport Inhibitors Using Yeast Overexpressing a Human MDR Transporter.
P2860
Q24633957-94F34120-8343-497F-B1D9-F997EE1887FAQ26860729-550ED171-3363-4D60-AF04-EFD817171DE6Q34473316-C79AC67F-1E44-4482-97F7-89EC57C6A452Q34887304-858F8F1F-39BF-4A12-94B6-9CCFEE2C99C3Q35084491-DB67BC3B-97D4-4D09-A591-EF61846B1D3AQ36165835-55995D20-9C8E-4898-BE97-04CC4945CA58Q36355946-5B4FAF17-7E53-41EA-962A-4B9A0407ADB8Q37945219-1497CF6A-39A6-492A-B992-5700A0164DCEQ38848885-410CE0F8-0A49-41C1-969D-11C12682CB6EQ38994079-1BDAECBE-E159-4C3C-94F8-EC0E90BA3969Q39366114-7F6560EF-E67C-44E7-9249-3A1B7CE8A383Q39547622-46123D6F-38B7-436F-B40D-85A875147336Q39652106-1C1F8605-0EF2-4825-8F82-1B7A4CE6A792Q39792514-36851BF5-B16F-4D88-9B49-58433F1D292AQ45344125-5C4ADB3A-128E-4869-86DC-47EF7F4FC9A4Q51598522-C41E1F22-DE73-4EFC-820F-F7B239E7505D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer, stem cells, and oncolytic viruses.
@en
Cancer, stem cells, and oncolytic viruses.
@nl
type
label
Cancer, stem cells, and oncolytic viruses.
@en
Cancer, stem cells, and oncolytic viruses.
@nl
prefLabel
Cancer, stem cells, and oncolytic viruses.
@en
Cancer, stem cells, and oncolytic viruses.
@nl
P2860
P1433
P1476
Cancer, stem cells, and oncolytic viruses.
@en
P2093
Camilla Ribacka
Sari Pesonen
P2860
P304
P356
10.1080/07853890802021342
P407
P577
2008-01-01T00:00:00Z